Dentium CO., LTD (KRX:145720)

Market Cap	616.61B
Revenue (ttm)	413.29B
Net Income (ttm)	85.99B
Shares Out	8.62M
EPS (ttm)	9,970.84
PE Ratio	7.17
Forward PE	7.68
Dividend	400.00 (0.57%)
Ex-Dividend Date	Dec 27, 2024

Volume	47,490
Average Volume	50,375
Open	74,700
Previous Close	75,000
Day's Range	73,600 - 75,600
52-Week Range	54,000 - 148,500
Beta	0.99
RSI	55.42
Earnings Date	Feb 28, 2025

About Dentium CO., LTD

Dentium CO., LTD manufactures and sells dental medical instrument worldwide. Its implant systems include superline, implantium, implantium 2, N.R. line, simple line 2, and slim line. The company also provides block and coloring; regeneration products; and digital dentistry products. In addition, it offers orthodontics, bright resin, tooth care, and other dental products. The company was formerly known as Biostech Co., Ltd. and changed its name to Dentium Co.,Ltd. in August 2002. Dentium Co.,Ltd. was founded in 2000 and is headquartered in Seoul...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 2000
• Employees: 800
• Stock Exchange: Korea Stock Exchange
• Ticker Symbol: 145720

Financial Performance

In 2023, Dentium CO., LTD's revenue was 393.19 billion, an increase of 10.49% compared to the previous year's 355.87 billion. Earnings were 96.52 billion, an increase of 12.15%.